Home >

Top Features


Advertisement

Features

May 16, 2023
Dr. Monica M. Bertagnolli will receive the 2023 Allen Lichter Visionary Leader Award in recognition of her work to improve the understanding of cancer and develop innovations that promote high-quality care.
Apr 21, 2023
ASCO honors Dr. María Teresa Bourlon with the 2023 Conquer Cancer, the ASCO Foundation, International Women Who Conquer Cancer Mentorship Award for her dedication to mentoring women training to be cancer clinicians, educators, and researchers.

Exclusive Journals Coverage

Mar 08, 2023
JCO published a special series that features perspectives from a wide range of renowned experts in drug development, including regulators, bioethicists, statisticians, clinician-scientists, and stakeholders in industry and beyond. 
Nov 10, 2022
The series illustrates how innovation is making significant strides in securing better access to the technologies and approaches that will have a positive impact on cancer control and health equity across the globe.

Current Controversies in Oncology

Jul 17, 2018
The era of precision medicine in oncology offers promise for improved diagnosis and better therapy for patients with the CUP syndrome, and first steps have already been taken toward incorporating precision medicine into the routine management of disease in these patients. 
Apr 25, 2018
Drs. Sarah W. Gordon, Sarah M. Temkin, Debra L. Richardson, and Kathleen Moore debate the role of maintenance PARP in platinum-sensitive ovarian cancer.

ASCO International

Mar 28, 2023
ASCO is pleased to announce the leaders selected for the 2023-2024 Leadership Development Program Asia Pacific (LDP-AP). 
Mar 09, 2023
After completing the IDEA program, Dr. Rubagumya, Dr. Tamamyan, and Dr. Amayiri each went on to apply for and receive a (LIFe) grant.

Trainee & Early-Career Oncologists

Jun 03, 2023
Test your knowledge of leukemia and lymphoma with two multiple-choice questions from the ASCO Self-Evaluation Program (ASCO-SEP) on ASCO Education.
May 30, 2023
Dr. Chen’s research focuses on clinical trial development and experimental therapies as well as outcomes in melanoma and thoracic malignancies.